Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
Human Reproduction (Oxford, England)
|
June 1, 1994
Hepatic metabolism and distribution of mifepristone and its metabolites in rats
O Heikinheimo, U Pesonen, R Huupponen, et al.
European Journal of Pharmacology
|
April 6, 1993
Effect of chronic treatment with TFMPP, a 5-HT1 receptor agonist, on food intake, weight gain, plasma insulin and neuropeptide mRNA expression in obese Zucker rats
J Rouru, U Pesonen, K Isaksson, et al.
European Journal of Pharmacology
|
July 8, 1998
Effects of ZD7114, a selective beta3-adrenoceptor agonist, on neuroendocrine mechanisms controlling energy balance
E Savontaus, U Pesonen, J Rouru, et al.
Annals of Medicine
|
January 27, 1999
Neuropeptide Y: a novel link between the neuroendocrine system and cholesterol metabolism
M I Uusitupa, M K Karvonen, U Pesonen, et al.
Neuroendocrinology
|
November 1, 1990
Hypothalamic neurochemistry and feeding behavioral responses to clonidine, an alpha-2-agonist, and to trifluoromethylphenylpiperazine, a putative 5-hydroxytryptamine-1B agonist, in genetically obese Zucker rats
M Koulu, R Huupponen, H Hänninen, et al.
British Journal of Clinical Pharmacology
|
June 10, 2000
Influence of hydroxychloroquine on the bioavailability of oral metoprolol
M Somer, J Kallio, U Pesonen, et al.
Pharmacology & Toxicology
|
March 1, 1993
Reduced turnover of dopamine and 5-hydroxytryptamine in discrete dopaminergic, noradrenergic and serotonergic rat brain areas after acutely administered medetomidine, a selective alpha 2-adrenoceptor agonist
M Koulu, U Pesonen, S Koskinen, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
May 18, 2006
The Leu7Pro polymorphism of neuropeptide Y is associated with younger age of onset of type 2 diabetes mellitus and increased risk for nephropathy in subjects with diabetic retinopathy
U Jaakkola, U Pesonen, E Vainio-Jylhä, et al.
British Journal of Pharmacology
|
August 1, 1995
Effects of metformin treatment on glucose transporter proteins in subcellular fractions of skeletal muscle in (fa/fa) Zucker rats
J Rouru, M Koulu, J Peltonen, et al.
Pharmacology, Biochemistry, and Behavior
|
April 15, 2000
Effects of chronic celiprolol treatment on brown fat, feeding, and drinking in fa/fa Zucker rats
E Savontaus, J Rouru, K Malminiemi, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
Human Reproduction (Oxford, England)
|
June 1, 1994
Hepatic metabolism and distribution of mifepristone and its metabolites in rats
O Heikinheimo, U Pesonen, R Huupponen, et al.
European Journal of Pharmacology
|
April 6, 1993
Effect of chronic treatment with TFMPP, a 5-HT1 receptor agonist, on food intake, weight gain, plasma insulin and neuropeptide mRNA expression in obese Zucker rats
J Rouru, U Pesonen, K Isaksson, et al.
European Journal of Pharmacology
|
July 8, 1998
Effects of ZD7114, a selective beta3-adrenoceptor agonist, on neuroendocrine mechanisms controlling energy balance
E Savontaus, U Pesonen, J Rouru, et al.
Annals of Medicine
|
January 27, 1999
Neuropeptide Y: a novel link between the neuroendocrine system and cholesterol metabolism
M I Uusitupa, M K Karvonen, U Pesonen, et al.
Neuroendocrinology
|
November 1, 1990
Hypothalamic neurochemistry and feeding behavioral responses to clonidine, an alpha-2-agonist, and to trifluoromethylphenylpiperazine, a putative 5-hydroxytryptamine-1B agonist, in genetically obese Zucker rats
M Koulu, R Huupponen, H Hänninen, et al.
British Journal of Clinical Pharmacology
|
June 10, 2000
Influence of hydroxychloroquine on the bioavailability of oral metoprolol
M Somer, J Kallio, U Pesonen, et al.
Pharmacology & Toxicology
|
March 1, 1993
Reduced turnover of dopamine and 5-hydroxytryptamine in discrete dopaminergic, noradrenergic and serotonergic rat brain areas after acutely administered medetomidine, a selective alpha 2-adrenoceptor agonist
M Koulu, U Pesonen, S Koskinen, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
May 18, 2006
The Leu7Pro polymorphism of neuropeptide Y is associated with younger age of onset of type 2 diabetes mellitus and increased risk for nephropathy in subjects with diabetic retinopathy
U Jaakkola, U Pesonen, E Vainio-Jylhä, et al.
British Journal of Pharmacology
|
August 1, 1995
Effects of metformin treatment on glucose transporter proteins in subcellular fractions of skeletal muscle in (fa/fa) Zucker rats
J Rouru, M Koulu, J Peltonen, et al.
Pharmacology, Biochemistry, and Behavior
|
April 15, 2000
Effects of chronic celiprolol treatment on brown fat, feeding, and drinking in fa/fa Zucker rats
E Savontaus, J Rouru, K Malminiemi, et al.
Page
of 5